All News Top News May 29, 2019 Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress Learn More Share Top News May 28, 2019 Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) Extended-Release Tablets in the United States Learn More Share Top News May 26, 2019 Company Statement: Teva Reaches Agreement with State of Oklahoma to Resolve State’s Claims Against the Company Learn More Share Top News May 10, 2019 Teva Announces the Launch of a Generic Version of Delzicol® (mesalamine) Delayed-Release Capsules in the United States Learn More Share Top News May 9, 2019 Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States Learn More Share
Top News May 29, 2019 Teva to present new fremanezumab FOCUS Clinical Study Data for the first time at the 13th European Headache Federation Congress Learn More
Top News May 28, 2019 Teva Announces Launch of a Generic Version of Ranexa® (ranolazine) Extended-Release Tablets in the United States Learn More
Top News May 26, 2019 Company Statement: Teva Reaches Agreement with State of Oklahoma to Resolve State’s Claims Against the Company Learn More
Top News May 10, 2019 Teva Announces the Launch of a Generic Version of Delzicol® (mesalamine) Delayed-Release Capsules in the United States Learn More
Top News May 9, 2019 Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States Learn More